Trademarkia Logo

Canada

C$
Trademark Search in Canada
INNOVENT & DESIGN

View On IC.GC.CA

INNOVENT & DESIGN
REGISTERED

on 25 Feb 2021

Last Applicant/ Owned by

INNOVENT BIOLOGICS (SUZHOU) CO. LTD.

No. 168, Dongping StreetSuzhou Industrial ParkSuzhou City, 215123

CN

Serial Number

1869705 filed on 24th Nov 2017

Registration Number

TMA1094377 registered on 25th Feb 2021

Registration expiry Date

25th Feb 2031

Correspondent Address

NELLIGAN O'BRIEN PAYNE LLP

300-50 O'CONNOR STREETOTTAWA

ONTARIO

CA

K1P6L2

INNOVENT & DESIGN

Trademark usage description

medicines for human purposes, namely medicines for the treatment of cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; p Read More

Vienna Information

1 . 7 . 19

Several crescents or half-moonsPlusieurs croissants ou demi-lunes

1 . 15 . 23

Vortices, rotary movements, tornadoes -- Note: Not including astronomic orbits (1.13.1), atomic orbits (1.13.1), concentric circles (26.1.4 or 26.1.5) and spirals (26.1.5).Tourbillons, mouvements rotatifs, tornade -- Note: Non compris les orbites astronomiques (1.13.1), les orbites atomiques (1.13.1), les cercles concentriques (26.1.4 ou 26.1.5) et les spirales (26.1.5).

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 15

Letters or numerals representing an objectLettres ou chiffres représentant un objet

Classification Information

Class [005]
Medicines for human purposes, namely medicines for the treatment of cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Pharmaceutical preparations for the treatment of cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Vaccines for the prevention and treatment of cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Drugs for the treatment of cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Biological preparations for the treatment of cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Diagnostic preparations for clinical laboratory use; Diagnostic preparations for medical laboratory use; Diagnostic preparations for medical research use; Biological tissue cultures for medical purposes; Chemical preparations for the treatment of cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Pre-filled syringes for medical purposes containing pharmaceutical preparations, namely pharmaceutical preparations for the treatment of cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Antibiotics.

Classification kind code

11

Class [035]
Import-export agencies.

Classification kind code

11

Class [042]
Technical research in the fields of pharmaceutical studies on cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Medical laboratory services; Scientific research in the fields of pharmaceutical studies on cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Biological research in the fields of pharmaceutical studies on cancers, ophthalmologic diseases, autoimmune disorders, cardiovascular diseases; Clinical trials.

Classification kind code

11

Mark Details

Serial Number

1869705

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 27
on 7th Oct 2020		Approval Notice Sent
Submitted for opposition 12
on 8th Jul 2020		Extension of Time
Submitted for opposition 12
on 13th Aug 2019		Extension of Time
Submitted for opposition 87
on 16th Apr 2019		Rep for Service Changed
Submitted for opposition 48
on 16th Apr 2019		Agent Changed
Submitted for opposition 22
on 16th Jan 2019		Search Recorded
Submitted for opposition 20
on 16th Jan 2019		Examiner's First Report
Submitted for opposition 31
on 30th Nov 2017		Formalized
Submitted for opposition 1
on 27th Nov 2017		Created
Submitted for opposition 30
on 24th Nov 2017		Filed